Event : The 2010 FDA warning letters: Revealing the critical conduct areas in clinical studies http://www.rsc.org/events/detail/6462/The%202010%20FDA%20warning%20letters%3a%20Revealing%20the%20critical%20conduct%20areas%20in%20clinical%20studies This is a feed for event : The 2010 FDA warning letters: Revealing the critical conduct areas in clinical studies Thu, 11 Sep 2014 13:13:13 +0100 6462 6462 http://www.rsc.org/events/detail/6462/The%202010%20FDA%20warning%20letters%3a%20Revealing%20the%20critical%20conduct%20areas%20in%20clinical%20studies The 2010 FDA warning letters: Revealing the critical conduct areas in clinical studies Event dates: 1 November 2011<br/>Event summary: This 90-minute webinar will review FDA warning letters in Clinical Trials and present critical parameters to watch out for in order to secure compliance whether you are running or monitoring a clini<br/>Event Venue: Online Event, Palo Alto, 94303, United States Thu, 11 Sep 2014 13:13:13 +0100 2014-09-11T13:13:13+01:00